EUVIMEDEUVIMED entdecken
Crossref

Periprocedural outcomes of embolic protection device use in carotid artery stenting

Santiago Callegari, Gaëlle Romain, Odaly S Balasquide Odeh, Christiany Tapia, Daniel Pinto, Mufti Mushfiqur Rahman, Aseem Vashist, Kim G Smolderen, Carlos Mena-Hurtado

Journal of Vascular Surgery · 2026

DOI: 10.1016/j.jvs.2025.10.004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Vascular Surgery, 2026. Verfasst von Santiago Callegari und 8 weiteren Autor:innen. Beteiligte Einrichtung: Vascular Medicine Outcomes Program, Department of Internal Medicine, Section of Cardiovascular Medicine, Yale University, New Haven, CT; Department o…. Hauptthemen laut MEDLINE: Embolic Protection Devices, Stents, Carotid Stenosis, Endovascular Procedures. Die Arbeit nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Carotid artery stenting (CAS) is frequently used in the management of carotid artery stenosis. Although the use of embolic protection devices (EPDs) is common, the association with lower mortality has been questioned. We aimed to assess the association between CAS with and without EPD and periprocedural stroke and mortality. METHODS: We included patients from the nationwide Vascular Quality Initiative registry who underwent CAS between 2015 and 2019. Patients undergoing transcarotid artery revascularization were excluded. Outcomes after CAS with either no EPD attempted or failed vs successful use of any EPD (distal or proximal) were analyzed in propensity score 1:1 matching cohort. Logistic regression was used to assess in-hospital mortality and stroke and transient ischemic attack outcomes (odds ratio [OR] with 95% confidence interval [CI]). Kaplan-Meier and Cox-proportional hazards regression were used to derive 30-day mortality cumulative incidence and risk. Analyses were replicated using inverse propensity weighting as a sensitivity analysis. RESULTS: A total of 19,451 patients were included, with 2062 per EPD group after 1:1 p propensity score matching (aged 67.1 ± 11.7 years; 41.4% female; 87.1% White). CAS without EPD was significantly associated with higher odds of in-hospital mortality (OR, 2.40; 95% CI, 1.50-3.85; P < .001), but not stroke/transient ischemia attack (OR, 1.26; 95% CI, 0.91-1.75; P = .160). The 30-day cumulative incidence and risk of death were twice as high in patients without vs with EPD (OR, 4.3% [95% CI, 3.5%-5.3%] vs OR, 2.0% [95% CI, 1.4%-2.7%]; P < .001; and hazard ratio, 2.21 [95% CI, 1.51-3.24]; P < .001). Sensitivity analysis revealed similar results. CONCLUSIONS: Not using an EPD was associated with higher in-hospital and 30-day mortality outcome in CAS when compared with EPD used. As the use of CAS increases, our real-world evidence highlights the risks of not using an EPD and the potential for including this metric as part of national quality improvement efforts for adequate CAS practices.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Embolic Protection DevicesStentsCarotid StenosisEndovascular ProceduresStrokeHumansFemaleAgedMaleRegistriesRisk FactorsTreatment OutcomeHospital MortalityRisk AssessmentMiddle AgedTime FactorsRetrospective StudiesIschemic Attack, TransientUnited StatesAged, 80 and over

Stichwörter der Autor:innen

Carotid artery diseaseCarotid stentingEmbolic protection devices

Autor:innen und Institutionen

  • Vascular Medicine Outcomes Program, Department of Internal Medicine, Section of Cardiovascular Medicine, Yale University, New Haven, CT; Department of Internal Medicine, Yale School of Medicine, New Haven, CT.
  • Vascular Medicine Outcomes Program, Department of Internal Medicine, Section of Cardiovascular Medicine, Yale University, New Haven, CT.
  • Vascular Medicine Outcomes Program, Department of Internal Medicine, Section of Cardiovascular Medicine, Yale University, New Haven, CT; University of Puerto Rico School of Medicine, Medical Sciences Campus, San Juan, P…
  • Vascular Medicine Outcomes Program, Department of Internal Medicine, Section of Cardiovascular Medicine, Yale University, New Haven, CT; Department of Psychiatry, Yale University, New Haven, CT.
  • Vascular Medicine Outcomes Program, Department of Internal Medicine, Section of Cardiovascular Medicine, Yale University, New Haven, CT. Electronic address: carlos.mena-hurtado@yale.edu.

Zitieren

APA

Callegari, S., Romain, G., Balasquide Odeh, O. S., Tapia, C., Pinto, D., Rahman, M. M., Vashist, A., Smolderen, K. G., & Mena-Hurtado, C. (2026). Periprocedural outcomes of embolic protection device use in carotid artery stenting. Journal of Vascular Surgery. https://doi.org/10.1016/j.jvs.2025.10.004

Vancouver

Callegari S, Romain G, Balasquide Odeh OS, Tapia C, Pinto D, Rahman MM, et al. Periprocedural outcomes of embolic protection device use in carotid artery stenting. Journal of Vascular Surgery. 2026. doi:10.1016/j.jvs.2025.10.004

BibTeX
@article{Callegari2026,
  author = {Callegari, Santiago and Romain, Gaëlle and Balasquide Odeh, Odaly S and Tapia, Christiany and Pinto, Daniel and Rahman, Mufti Mushfiqur and Vashist, Aseem and Smolderen, Kim G and Mena-Hurtado, Carlos},
  title = {Periprocedural outcomes of embolic protection device use in carotid artery stenting},
  journal = {Journal of Vascular Surgery},
  year = {2026},
  doi = {10.1016/j.jvs.2025.10.004}
}
Kostenlos starten →